+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application; By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 2022 - 2029

  • PDF Icon

    Report

  • 52 Pages
  • December 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5321994
Description Jump to:
The global artificial intelligence in drug discovery market size is expected to reach USD 5,558.0 million by 2029 according to this new study. The report “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Optimization & Repurposing, Preclinical testing, Others); By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 2022-2029” gives a detailed insight into current market dynamics and provides analysis on future market growth.





Artificial Intelligence (AI) uses complex algorithms and machine learning to acquire significant information from huge datasets. For instance, AI uses RNA sequencing data to recognize genes whose expression correlates with a given cellular condition. It employs the most recent advancements in biology to create cutting-edge medicine discovery algorithms. The increase in computer processing power, the development of advanced algorithms, and the availability of large datasets are the main drivers that led to the developments in machine learning.

Based on application, the global artificial intelligence (AI) in the drug discovery market is clustered into drug optimization & repurposing, preclinical testing, and others. The optimization & repurposing segment accounted for the largest revenue share in the industry as it is economical and demands only Electronic Medical Records (EMR) for medicine repurposing.

Based on therapeutic areas, the global market is classified into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. The oncology segment accounted for the largest revenue share in 2020 as it deals with the diagnosis and prevention of cancer.

There are some pharmaceutical companies that are focusing on integrating artificial intelligence with medicine discovery and development. For instance, Pfizer associated with IBM Watson Health, an AI platform, to augment their search for immuno-oncology treatments. Sanofi partnered with Exscientia to discover metabolic-disease therapies.

Major participants such as GNS Healthcare, DeepMind, BIOAGE, Atomwise, Euretos, Benevolent AI, OWKIN, Inc, Berg Health, BioSymetrics, Insitro, Cloud Pharmaceuticals, Cyclica, Deep Genomics, Envisagenics, Exscientia, IBM Corporation, Insilico Medicine, NuMedii, Numerate, NVIDIA Corporation, Aria Pharmaceuticals, Inc, Verge Genomics, XtalPi Inc are some of the key players operating in the global market. The companies in the industry are engaged in collaborations and expansions with several market platform providers to develop medical treatment.

The publisher has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, offering, technology, and region:


Artificial Intelligence in Drug Discovery, Application Outlook (Revenue-USD Million, 2017-2029)


  • Drug Optimization & Repurposing
  • Preclinical Testing
  • Others

Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue-USD Million, 2017-2029)


  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others

Artificial Intelligence in Drug Discovery, Offering Outlook (Revenue-USD Million, 2017-2029)


  • Software
  • Services

Artificial Intelligence in Drug Discovery, Technology Outlook (Revenue-USD Million, 2017-2029)


  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

Artificial Intelligence in Drug Discovery, Regional Outlook (Revenue-USD Million, 2017-2029)


  • North America
  • U.S
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Asia Pacific
  • China
  • Australia
  • Japan
  • Latin America
  • Middle East & Africa
Frequently Asked Questions about the Artificial Intelligence in Drug Discovery Market

What is the estimated value of the Artificial Intelligence in Drug Discovery Market?

The Artificial Intelligence in Drug Discovery Market was estimated to be valued at $626.6 Million in 2022.

What is the growth rate of the Artificial Intelligence in Drug Discovery Market?

The growth rate of the Artificial Intelligence in Drug Discovery Market is 36.6%, with an estimated value of $5558 Million by 2029.

What is the forecasted size of the Artificial Intelligence in Drug Discovery Market?

The Artificial Intelligence in Drug Discovery Market is estimated to be worth $5558 Million by 2029.

Who are the key companies in the Artificial Intelligence in Drug Discovery Market?

Key companies in the Artificial Intelligence in Drug Discovery Market include Atomwise, Benevolent AI, Berg Health, BIOAGE, BioSymetrics, Cloud Pharmaceuticals, Cyclica, Deep Genomics and Envisagenics.
Report AttributeDetails
No. of Pages52
PublishedDecember 2021
Forecast Period2022 - 2029
Estimated Market Value ( USD ) in 2022 USD   626.6 Million
Forecasted Market Value ( USD ) by 2029 USD   5558 Million
Compound Annual Growth Rate36.6%
Regions CoveredGlobal
No. of Companies Mentioned23

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Artificial Intelligence in Drug Discovery Market Insights
4.1. Artificial Intelligence in Drug Discovery - Industry Snapshot
4.2. Artificial Intelligence in Drug Discovery Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Technological advancements in AI
4.2.1.2. Rising industrial partnerships and collaborations
4.2.2. Restraints and Challenges
4.2.2.1. Inadequate accessibility of data sets
4.2.3. Porter’s Five Forces Analysis
4.2.3.1. Bargaining Power of Suppliers (Moderate)
4.2.3.2. Threats of New Entrants: (Low)
4.2.3.3. Bargaining Power of Buyers (Moderate)
4.2.3.4. Threat of Substitute (Moderate)
4.2.3.5. Rivalry among existing firms (High)
4.2.4. PESTLE Analysis
4.2.5. Artificial Intelligence in Drug Discovery Industry Trends
4.2.6. COVID-19 Impact Analysis
5. Global Artificial Intelligence in Drug Discovery Market, by Application
5.1. Key Findings
5.2. Introduction
5.2.1. Global Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
5.3. Drug Optimization & Repurposing
5.3.1. Global Artificial Intelligence in Drug Discovery Market, by Drug Optimization & Repurposing, by Region, 2017 - 2029 (USD Million)
5.4. Preclinical Testing
5.4.1. Global Artificial Intelligence in Drug Discovery Market, by Preclinical Testing, by Region, 2017 - 2029 (USD Million)
5.5. Others
5.5.1. Global Artificial Intelligence in Drug Discovery Market, by Other Applications, by Region, 2017 - 2029 (USD Million)
6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area
6.1. Key Findings
6.2. Introduction
6.2.1. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
6.3. Oncology
6.3.1. Global Artificial Intelligence in Drug Discovery Market, by Oncology, by Region, 2017 - 2029 (USD Million)
6.4. Neurodegenerative Diseases
6.4.1. Global Artificial Intelligence in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2017 - 2029 (USD Million)
6.5. Cardiovascular Disease
6.5.1. Global Artificial Intelligence in Drug Discovery Market, by Cardiovascular Disease, by Region, 2017 - 2029 (USD Million)
6.6. Metabolic Diseases
6.6.1. Global Artificial Intelligence in Drug Discovery Market, by Metabolic Diseases, by Region, 2017 - 2029 (USD Million)
6.7. Infectious Disease
6.7.1. Global Artificial Intelligence in Drug Discovery Market, by Infectious Disease, by Region, 2017 - 2029 (USD Million)
6.8. Others
6.8.1. Global Other Artificial Intelligence in Drug Discovery Market, by Region, 2017 - 2029 (USD Million)
7. Global Artificial Intelligence in Drug Discovery Market, by Offering
7.1. Key Findings
7.2. Introduction
7.2.1. Global Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
7.3. Software
7.3.1. Global Artificial Intelligence in Drug Discovery Market, by Software, By Region, 2017 - 2029 (USD Million)
7.4. Services
7.4.1. Global Artificial Intelligence in Drug Discovery Market, by Services, By Region, 2017 - 2029 (USD Million)
8. Global Artificial Intelligence in Drug Discovery Market, by Technology
8.1. Key Findings
8.2. Introduction
8.2.1. Global Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
8.3. Machine Learning
8.3.1. Global Artificial Intelligence in Drug Discovery Market, By Machine Learning, By Region, 2017 - 2029 (USD Million)
8.3.2. Deep Learning
8.3.2.1. Global Artificial Intelligence in Drug Discovery Market, By Deep Learning, By Region, 2017 - 2029 (USD Million)
8.3.3. Supervised Learning
8.3.3.1. Global Artificial Intelligence in Drug Discovery Market, By Supervised Learning, By Region, 2017 - 2029 (USD Million)
8.3.4. Reinforcement Learning
8.3.4.1. Global Artificial Intelligence in Drug Discovery Market, By Reinforcement Learning, By Region, 2017 - 2029 (USD Million)
8.3.5. Unsupervised Learning
8.3.5.1. Global Artificial Intelligence in Drug Discovery Market, By Unsupervised Learning, By Region, 2017 - 2029 (USD Million)
8.3.6. Other Machine Learning Technologies
8.3.6.1. Global Artificial Intelligence in Drug Discovery Market, By Other Machine Learning Technologies, By Region, 2017 - 2029 (USD Million)
8.4. Other Technologies
8.4.1. Global Artificial Intelligence in Drug Discovery Market, by Other Technologies, by Region, 2017 - 2029 (USD Million)
9. Global Artificial Intelligence in Drug Discovery Market, by Geography
9.1. Key findings
9.2. Introduction
9.2.1. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2017 - 2029 (USD Million)
9.3. Artificial Intelligence in Drug Discovery Market - North America
9.3.1. North America: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.3.2. North America: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.3.3. North America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.3.4. North America: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.3.5. Artificial Intelligence in Drug Discovery Market - U. S.
9.3.5.1. U. S.: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.3.5.2. U. S.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.3.5.3. U. S.: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.3.5.4. U. S.: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.3.6. Artificial Intelligence in Drug Discovery Market - Canada
9.3.6.1. Canada: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.3.6.2. Canada.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.3.6.3. Canada: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.3.6.4. Canada: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.4. Artificial Intelligence in Drug Discovery Market - Europe
9.4.1. Europe: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.4.2. Europe.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.4.3. Europe: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.4.4. Europe: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.4.5. Artificial Intelligence in Drug Discovery Market - UK
9.4.5.1. UK: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.4.5.2. UK.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.4.5.3. UK: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.4.5.4. UK: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.4.6. Artificial Intelligence in Drug Discovery Market - France
9.4.6.1. France: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.4.6.2. France.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.4.6.3. France: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.4.6.4. France: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.4.7. Artificial Intelligence in Drug Discovery Market - Germany
9.4.7.1. Germany: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.4.7.2. Germany.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.4.7.3. Germany: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.4.7.4. Germany: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.5. Artificial Intelligence in Drug Discovery Market - Asia Pacific
9.5.1. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.5.2. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.5.3. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.5.4. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.5.5. Artificial Intelligence in Drug Discovery Market - China
9.5.5.1. China: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.5.5.2. China: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.5.5.3. China: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.5.5.4. China: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.5.6. Artificial Intelligence in Drug Discovery Market - Australia
9.5.6.1. Australia: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.5.6.2. Australia.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.5.6.3. Australia: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.5.6.4. Australia: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.5.7. Artificial Intelligence in Drug Discovery Market - Japan
9.5.7.1. Japan: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.5.7.2. Japan: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.5.7.3. Japan: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.5.7.4. Japan: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.6. Artificial Intelligence in Drug Discovery Market - Latin America
9.6.1. Latin America: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.6.2. Latin America: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.6.3. Latin America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.6.4. Latin America: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
9.7. Artificial Intelligence in Drug Discovery Market - Middle East & Africa
9.7.1. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
9.7.2. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
9.7.3. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
9.7.4. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Aria Pharmaceuticals, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Atomwise
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Benevolent AI
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Berg Health
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. BIOAGE
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. BioSymetrics
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Cloud Pharmaceuticals
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Cyclica
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Deep Genomics
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. DeepMind
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Envisagenics
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Euretos
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
11.13. Exscientia
11.13.1. Company Overview
11.13.2. Financial Performance
11.13.3. Product Benchmarking
11.13.4. Recent Development
11.14. GNS Healthcare
11.14.1. Company Overview
11.14.2. Financial Performance
11.14.3. Product Benchmarking
11.14.4. Recent Development
11.15. IBM Corporation
11.15.1. Company Overview
11.15.2. Financial Performance
11.15.3. Product Benchmarking
11.15.4. Recent Development
11.16. Insilico Medicine
11.16.1. Company Overview
11.16.2. Financial Performance
11.16.3. Product Benchmarking
11.16.4. Recent Development
11.17. Insitro
11.17.1. Company Overview
11.17.2. Financial Performance
11.17.3. Product Benchmarking
11.17.4. Recent Development
11.18. NuMedii
11.18.1. Company Overview
11.18.2. Financial Performance
11.18.3. Product Benchmarking
11.18.4. Recent Development
11.19. Numerate
11.19.1. Company Overview
11.19.2. Financial Performance
11.19.3. Product Benchmarking
11.19.4. Recent Development
11.20. NVIDIA Corporation
11.20.1. Company Overview
11.20.2. Financial Performance
11.20.3. Product Benchmarking
11.20.4. Recent Development
11.21. OWKIN, Inc.
11.21.1. Company Overview
11.21.2. Financial Performance
11.21.3. Product Benchmarking
11.21.4. Recent Development
11.22. Verge Genomics
11.22.1. Company Overview
11.22.2. Financial Performance
11.22.3. Product Benchmarking
11.22.4. Recent Development
11.23. XtalPi Inc.
11.23.1. Company Overview
11.23.2. Financial Performance
11.23.3. Product Benchmarking
11.23.4. Recent Development
List of Tables
Table 1. Global Artificial Intelligence in Drug Discovery Market, by Application, by Region, 2017 - 2029 (USD Million)
Table 2. Global Artificial Intelligence in Drug Discovery Market, by Technology, by Region, 2017 - 2029 (USD Million)
Table 3. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, by Region, 2017 - 2029 (USD Million)
Table 4. Global Artificial Intelligence in Drug Discovery Market, by Offering, by Region, 2017 - 2029 (USD Million)
Table 5. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2017 - 2029 (USD Million)
Table 6. North America: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 7. North America: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 8. North America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 9. North America: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 10. U.S.: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 11. U.S.: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 12. U.S.: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 13. U.S.: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 14. Canada: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 15. Canada: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 16. Canada: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 17. Canada: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 18. Europe: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 19. Europe: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 20. Europe: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 21. Europe: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 22. UK: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 23. UK: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 24. UK: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 25. UK: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 26. France: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 27. France: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 28. France: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 29. France: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 30. Germany: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 31. Germany: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 32. Germany: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 33. Germany: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 34. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 35. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 36. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 37. Asia Pacific: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 38. China: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 39. China: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 40. China: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 41. China: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 42. Australia: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 43. Australia: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 44. Australia: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 45. Australia: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 46. Japan: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 47. Japan: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 48. Japan: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 49. Japan: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 50. Latin America: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 51. Latin America: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 52. Latin America: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 53. Latin America: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
Table 54. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Application, 2017 - 2029 (USD Million)
Table 55. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Technology, 2017 - 2029 (USD Million)
Table 56. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 - 2029 (USD Million)
Table 57. Middle East & Africa: Artificial Intelligence in Drug Discovery Market, by Offering, 2017 - 2029 (USD Million)
List of Figures
Figure 1. Global Artificial Intelligence in Drug Discovery Market, 2017 - 2029 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter’s Five Forces
Figure 6. Market by Application
Figure 7. Global Artificial Intelligence in Drug Discovery Market, by Application, 2021 & 2029 (USD Million)
Figure 8. Market by Technology
Figure 9. Global Artificial Intelligence in Drug Discovery Market, by Technology, 2021 & 2029 (USD Million)
Figure 10. Market by Therapeutic Area
Figure 11. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2021 & 2029 (USD Million)
Figure 12. Market by Offering
Figure 13. Global Artificial Intelligence in Drug Discovery Market, by Offering, 2021 & 2029 (USD Million)
Figure 14. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2017 - 2029 (USD Million)
Figure 15. Strategic Analysis - Artificial Intelligence in Drug Discovery Market

Companies Mentioned

  • Atomwise
  • Benevolent AI
  • Berg Health
  • BIOAGE
  • BioSymetrics
  • Cloud Pharmaceuticals
  • Cyclica
  • Deep Genomics
  • DeepMind
  • Envisagenics
  • Euretos
  • Exscientia
  • GNS Healthcare
  • IBM Corporation
  • Insilico Medicine
  • Insitro
  • NuMedii
  • Numerate
  • NVIDIA Corporation
  • OWKIN Inc.
  • Aria Pharmaceuticals Inc.
  • Verge Genomics
  • XtalPi Inc.

Related Topics

Related Reports

AI in Genomics Market by Offering (Software, Services), Functionality (Sequencing, Gene Editing), Application (Diagnostics, Precision Medicine, Drug Discovery and Development), Delivery Mode (On-premise, Cloud), and End User-Global Forecast to 2029 - Product Image

AI in Genomics Market by Offering (Software, Services), Functionality (Sequencing, Gene Editing), Application (Diagnostics, Precision Medicine, Drug Discovery and Development), Delivery Mode (On-premise, Cloud), and End User-Global Forecast to 2029

  • Report
  • 162 Pages
  • Region: Global
From
Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024 - Product Image

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024

  • Report
  • 193 Pages
  • Region: Global
From
Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report by Application (Drug Optimization & Repurposing, Preclinical Testing), by Therapeutic Area, by Region, and Segment Forecasts, 2022-2030 - Product Image

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report by Application (Drug Optimization & Repurposing, Preclinical Testing), by Therapeutic Area, by Region, and Segment Forecasts, 2022-2030

  • Report
  • 80 Pages
  • Region: Global
From
2023 Global Forecast for Artificial Intelligence (Ai) In Drug Discovery Market (2024-2029 Outlook)- High Tech & Emerging Markets Report - Product Image

2023 Global Forecast for Artificial Intelligence (Ai) In Drug Discovery Market (2024-2029 Outlook)- High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Region: Global
From
Artificial Intelligence in Drug Discovery Market by Offering, Technology, Application, End User, and by Region - Global Forecast to 2022-2033 - Product Image

Artificial Intelligence in Drug Discovery Market by Offering, Technology, Application, End User, and by Region - Global Forecast to 2022-2033

  • Report
  • 200 Pages
  • Region: Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.